1. Abstract L17 from the American College of Rheumatology congress, November 2007. Emery P. et al. Remission rates with the combination of etanercept and methotrexate compared with methotrexate monotherapy in subjects with active early rheumatoid arthritis: 1-year COMET randomised double-blind results
2. Oral presentation. Emery P. et al. Remission Rates in Subjects With Active Early Rheumatoid Arthritis - 1 Year Results of COMET: Combination of Methotrexate and Etanercept in Active Early Rheumatoid Arthritis. Slide presentation at the American College of Rheumatology congress, November 2007.
3. Isik A et al Clinical Rheum. 2007;26:872-878
4. Burton W et al. Occup Med. 2006:56:18-27
5. Linn W et al Am J Public Health. 1985;75:502-506
6. Puolakka K et al, ARD. 2006;65:899-904
7. Enbrel EMEA SPC
For further information, please contact: Wyeth: Gill Markham, Communications - Europe, Middle East and Africa, Direct tel +44-1628-692536, Email: markhagl@wyeth.com; OgilvyHealthPR: Karen Crum, Direct Tel: +44-207-108-6411, Email: karen.crum@ohpr.com; Jodi Lewis, Direct Tel: +44-207-108-6086, Email: jodi.lewis@ohpr.com
